Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

Based on the latest financial reports, Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.11 Million ≈ $12.89 Million USD) by net assets (CN¥2.73 Billion ≈ $399.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300357 total liabilities for a breakdown of total debt and financial obligations.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
NCR Atleos Corporation NYSE:NATL	0.442x
Tatung Co TW:2371	-0.009x
Dalrymple Bay Infrastructure Ltd AU:DBI	-0.005x
TD Power Systems Limited NSE:TDPOWERSYS	0.013x
PARK24 SPONS. ADR/1 F:3WN	N/A
Yangling Metron New Material Co Ltd SHE:300861	-0.003x
Guanglian Aviation Industry Co Ltd SHE:300900	-0.015x
K+S Aktiengesellschaft F:SDF1	0.038x

Annual Cash Flow Conversion Efficiency for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.46 Billion ≈ $359.80 Million	CN¥262.44 Million ≈ $38.40 Million	0.107x	-36.68%
2023-12-31	CN¥2.30 Billion ≈ $337.10 Million	CN¥388.32 Million ≈ $56.82 Million	0.169x	-5.16%
2022-12-31	CN¥2.03 Billion ≈ $296.63 Million	CN¥360.28 Million ≈ $52.72 Million	0.178x	-11.44%
2021-12-31	CN¥1.80 Billion ≈ $262.90 Million	CN¥360.58 Million ≈ $52.76 Million	0.201x	+19.70%
2020-12-31	CN¥1.53 Billion ≈ $223.62 Million	CN¥256.22 Million ≈ $37.49 Million	0.168x	-2.68%
2019-12-31	CN¥1.35 Billion ≈ $197.83 Million	CN¥232.93 Million ≈ $34.08 Million	0.172x	-16.93%
2018-12-31	CN¥995.42 Million ≈ $145.66 Million	CN¥206.45 Million ≈ $30.21 Million	0.207x	+4.43%
2017-12-31	CN¥801.26 Million ≈ $117.25 Million	CN¥159.13 Million ≈ $23.29 Million	0.199x	+6.05%
2016-12-31	CN¥655.58 Million ≈ $95.93 Million	CN¥122.77 Million ≈ $17.97 Million	0.187x	-4.93%
2015-12-31	CN¥582.91 Million ≈ $85.30 Million	CN¥114.82 Million ≈ $16.80 Million	0.197x	+20.85%
2014-12-31	CN¥513.55 Million ≈ $75.15 Million	CN¥83.70 Million ≈ $12.25 Million	0.163x	-29.58%
2013-12-31	CN¥251.92 Million ≈ $36.86 Million	CN¥58.30 Million ≈ $8.53 Million	0.231x	+1.97%
2012-12-31	CN¥181.38 Million ≈ $26.54 Million	CN¥41.17 Million ≈ $6.02 Million	0.227x	+51.24%
2011-12-31	CN¥127.61 Million ≈ $18.67 Million	CN¥19.15 Million ≈ $2.80 Million	0.150x	-6.64%
2010-12-31	CN¥90.44 Million ≈ $13.23 Million	CN¥14.54 Million ≈ $2.13 Million	0.161x	+42.42%
2009-12-31	CN¥111.89 Million ≈ $16.37 Million	CN¥12.63 Million ≈ $1.85 Million	0.113x	--

About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

SHE:300357 China Drug Manufacturers - General

Market Cap

$1.95 Billion

CN¥13.30 Billion CNY

Market Cap Rank

#6382 Global

#1424 in China

Share Price

CN¥25.40

Change (1 day)

-1.82%

52-Week Range

CN¥19.38 - CN¥35.30

All Time High

CN¥5101.55